The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

People living with type 2 diabetes face several significant health challenges. The condition, which affects more than 10% of ...

Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...

KHOU 11 News anchor Rekha Muddaraj spoke to an endocrinologist with UT Physicians about the chronic disease and what to look ...

IDF creating new Type 2 diabetes guidelines with global experts, focusing on patient-centered care and global accessibility.

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...

In recent years, the medical community has been reevaluating traditional approaches to managing type 2 diabetes. A groundbreaking study has shed new light on ...

The detailed results were published in The New England Journal of Medicine and were presented at ObesityWeek 2024.

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

A new study found that over 800 million adults have diabetes worldwide — almost twice as many as previous estimates have ...